Document Detail


Long-term reduction of microalbuminuria after 3 years of angiotensin-converting enzyme inhibition by perindopril in hypertensive insulin-treated diabetic patients.
MedLine Citation:
PMID:  1580274     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We studied the long-term effects of the angiotensin-converting enzyme (ACE) inhibitor perindopril, administered for 36 months on glycemic control, creatinine clearance, and albuminuria in hypertensive insulin-treated diabetics. After 1 month treatment with placebo, 39 patients entered the study and received 4-8 mg perindopril/day. Within the first 3 months, diastolic blood pressure was normalized in 80% of the patients. From these, 23 were followed during a total of 3 years on perindopril therapy, and divided in three groups according to their initial urinary albumin excretion rate (AER): 11 had normal AER (less than 15 mg/24 hours), eight had microalbuminuria (AER 15-150 mg/24 hour), and four had AER greater than 150 mg/24 hours and had overt proteinuria. Long-term (3 years) diastolic blood pressure normalization (less than or equal to 90 mm Hg) was achieved throughout the study. Concomitant with blood pressure reduction, a long-term decrease in AER was observed in normo- and microalbuminuric patients. Macroproteinuria was unaffected by perindopril. Glycemic control and creatinine clearance remained stable during the whole study period. No major side effects were observed. We conclude that perindopril safely produces a long-term normalization of elevated blood pressure in hypertensive insulin-treated diabetics without affecting glycemic control. Blood pressure normalization is associated with long-term AER reduction in normo- and microalbuminuric patients.
Authors:
M P Hermans; S M Brichard; I Colin; P Borgies; J M Ketelslegers; A E Lambert
Related Documents :
6998684 - Comparison of the acute and chronic hemodynamic effects of captopril and guanethidine i...
3534854 - Influence of captopril on intracellular ions--a possible mode of action.
9048344 - Angiotensin-converting enzyme inhibition in the prevention and treatment of chronic ren...
8385284 - Renal responses to nifedipine and captopril in hypertensive insulin-dependent diabetic ...
8477024 - Potential risks of high-dose epinephrine for resuscitation from ventricular fibrillatio...
8262724 - Effect of calculus and irrigator tip design on depth of subgingival irrigation.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The American journal of medicine     Volume:  92     ISSN:  0002-9343     ISO Abbreviation:  Am. J. Med.     Publication Date:  1992 Apr 
Date Detail:
Created Date:  1992-06-05     Completed Date:  1992-06-05     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0267200     Medline TA:  Am J Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  102S-107S     Citation Subset:  AIM; IM    
Affiliation:
Department of Internal Medicine, Louvain University School of Medicine, Brussels, Belgium.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Albuminuria / complications,  drug therapy*
Analysis of Variance
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Blood Glucose / analysis
Creatinine / metabolism
Diabetes Complications*
Diabetes Mellitus / drug therapy
Diabetic Nephropathies / complications,  drug therapy*
Female
Humans
Hypertension / complications,  drug therapy*
Indoles / therapeutic use*
Insulin / therapeutic use
Male
Middle Aged
Perindopril
Chemical
Reg. No./Substance:
0/Angiotensin-Converting Enzyme Inhibitors; 0/Blood Glucose; 0/Indoles; 11061-68-0/Insulin; 60-27-5/Creatinine; 82834-16-0/Perindopril

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Diagnosis and interventions in lower respiratory tract infections.
Next Document:  Effect of the renin-angiotensin system in the vascular disease of type II diabetes mellitus.